Dyne Therapeutics, Inc. (DYN) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Biotechnology उद्योग. कंपनी का मुख्यालय है Waltham, MA, United States. वर्तमान CEO हैं John G. Cox.
DYN के पास है IPO तिथि 2020-09-17, 192 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $3.27B.
Dyne Therapeutics, Inc. is a biotechnology company focused on developing disease-modifying therapeutics for genetically driven muscle diseases. The company leverages its proprietary FORCE platform to advance treatment programs for myotonic dystrophy type 1, Duchenne muscular dystrophy, facioscapulohumeral dystrophy, and other rare skeletal, cardiac, and metabolic muscle diseases. Founded in 2017 and headquartered in Waltham, Massachusetts, Dyne operates primarily in the United States market, addressing significant unmet medical needs in the muscle disease therapeutic space.
